Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Jupiter Neurosciences
AddedFeb 15, 2024
UpdatedJul 9, 2026
Jupiter Neurosciences

Jupiter Neurosciences

Public

Jupiter Neurosciences: A biotech firm specializing in treatments for Alzheimer's and rare diseases.

HQ
Jupiter, FL, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Jupiter Neurosciences, founded with the mission to significantly impact patients and society, is a biotechnology company specializing in treatments for Alzheimer's disease and rare neurological disorders. The company focuses on developing JOTROL™, a clinical-stage drug platform aimed at treating neuroinflammation. Utilizing their proprietary Micellar Technology, Jupiter Neurosciences has created the first resveratrol product that safely reaches therapeutic levels without gastrointestinal side effects, opening up treatment possibilities for various conditions.

Notable figures affiliated with Jupiter Neurosciences include experts in neurology and biotechnology, although specific names are not provided. The company has attracted attention from investors interested in innovative treatments for neurodegenerative diseases. Key achievements include advancing JOTROL™ to clinical stages and demonstrating its potential to safely treat neuroinflammation. Jupiter Neurosciences' impact lies in its pioneering approach to addressing unmet medical needs in both common and rare neurological disorders.

Jupiter Neurosciences - Similar Companies

Jupiter Therapeutics logo

Jupiter Therapeutics

Intellect Neurosciences logo

Intellect Neurosciences

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

NeuroCytonix logo

NeuroCytonix

neurocytonix.com

Neuraly logo

Neuraly

neuralymed.com

Cerebral Therapeutics logo

Cerebral Therapeutics

NeuroTherapia logo

NeuroTherapia

neurotherapia.com

Minerva Neurosciences logo

Minerva Neurosciences

Astrocyte Pharmaceuticals logo

Astrocyte Pharmaceuticals

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Alto Neuroscience logo

Alto Neuroscience

Enterin logo

Enterin

enterininc.com

NeuroPro Therapeutics logo

NeuroPro Therapeutics

Empyrean Neuroscience logo

Empyrean Neuroscience

empyrean.bio

Receptor Life Sciences logo

Receptor Life Sciences

receptorlife.com

Jupiter Neurosciences - Quick Facts

Who are Jupiter Neurosciences' competitors?

Companies similar to Jupiter Neurosciences include Jupiter Therapeutics, Intellect Neurosciences, Reservoir Neuroscience and NeuroCytonix.

When was Jupiter Neurosciences founded?

Jupiter Neurosciences was founded in 2015.

Where is Jupiter Neurosciences' headquarters located?

Jupiter Neurosciences' headquarters is located in Jupiter, FL, US.

How much has Jupiter Neurosciences raised to-date?

As of Jan 1, 2021, Jupiter Neurosciences has raised a total of $2.8M (USD).

How many employees does Jupiter Neurosciences have?

Jupiter Neurosciences has 15 employees as of Feb 5, 2024.

Jupiter Neurosciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
Unique IDs
  • ein: 474828381
  • secCik: 0001679628
  • ticker: JUNS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research